英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
paygrade查看 paygrade 在百度字典中的解释百度英翻中〔查看〕
paygrade查看 paygrade 在Google字典中的解释Google英翻中〔查看〕
paygrade查看 paygrade 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Press Release - SEC. gov
    PDL’s Queen patents are related to the humanization of antibodies Soliris was approved in the U S and European Union in 2007 as a treatment for patients with paroxysmal nocturnal hemoglobinuria (“PNH”), a rare, debilitating and life-threatening blood disease
  • UCB and PDL BioPharma Resolve Patent Disputes
    No additional payments will be owed by UCB to PDL under the Queen patents in respect of Cimzia sales for any indication and the sale of a product in development that may or may not be approved within the term of the Queen patents
  • Alexion Pharmaceuticals and PDL BioPharma Resolve Patent Dispute
    Further, Alexion has agreed not to challenge or assist other parties in challenging the validity of the Queen patents in the future PDL's Queen patents are related to the humanization
  • Queen Patents Definition | Law Insider
    All decisions relating to interferences or oppositions lodged against the Queen Patents, including whether to initiate such interferences, appropriate settlement strategy, along with other strategic decisions relating to the Queen Patents, shall be made solely by PDL
  • UCB and PDL BioPharma Resolve Patent Disputes
    No additional payments will be owed by UCB to PDL under the Queen patents in respect of Cimzia® sales for any indication and the sale of a product in development that may or may not be approved within the term of the Queen patents
  • Genentech, PDL BioPharma, Inc. Signs Pact To Resolve All . . . - BioSpace
    PDL BioPharma manages a portfolio of patents and royalty assets, consisting primarily of its Queen et al antibody humanization patents and license agreements with various biotechnology and pharmaceutical companies
  • U. S. Patent and Trademark Office Terminates Interference . . . - pdl. com
    PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases PDL is focused on maximizing the value of its antibody humanization patents and related assets
  • UCB, UCB Pharma and PDL have resolved all disputes
    The definitive settlement agreement relates to all legal disputes, including those relating to UCB’s pegylated humanized antibody fragment, Cimzia® (certolizumab pegol) and PDL’s patents known as the Queen et al patents
  • UCB and PDL settle patent disputes over Cimzia; Natco challenges Gilead . . .
    No additional payments will be owed by UCB to PDL under the Queen patents in respect of Cimzia sales for any indication and the sale of a product in development that may or may not be approved within the term of the Queen patents
  • Settlement Agreement - SEC. gov
    Under the agreements announced today, PDL has granted Alexion a license under certain claims in the Queen patent portfolio, and provided Alexion a covenant not to sue in respect of other claims in the Queen patent portfolio, thus permitting Alexion to commercialize Soliris ® for all indications under the Queen patents





中文字典-英文字典  2005-2009